Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

The Fellow on Call: The Heme/Onc Podcast

コンテンツは Ronak Mistry and Rouleaux University Medical Center によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャストコンテンツは、Ronak Mistry and Rouleaux University Medical Center またはそのポッドキャストプラットフォームパートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。

1y ago

MP3•エピソードのホーム

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!

Content:

- Definitions for "primary refractory" vs. "relapsed" disease

- How do we approach patients with primary refractory disease?

- What are the treatment regimens for patients with primary refractory disease?

- What is the role of CAR-T therapy?

- How do we "bridge" patients to CAR-T therapy?

- How do we monitor patients post CAR-T?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

129 つのエピソード